• 
  InnoCare Releases 2025 Interim Results and Business Highlights PharmaSources.com
  August 20, 2025
  InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on cancer and autoimmune diseases, today announced the 2025 interim results as of 30 June 2025.
• 
  A Brief Overview of Emerging Target: STEAP Xiaobin
  July 11, 2025
  As the "low-hanging fruit" in drug discovery becomes increasingly scarce, pharmaceutical companies are shifting their focus toward novel targets. At this year's AACR Annual Meeting, AstraZeneca unveiled preclinical data for AZD0516, a drug candidate targe
• 
  2025 Q1: Oncology Business Competition Among MNCs Xiaobin
  June 04, 2025
  How did MNCs fare in the oncology field during Q1 of this year?

• 
  Water Treatment Plant in the Pharmaceutical Industry Muhammad Asim Niazi
  August 04, 2025
  Water is the basic raw material used in the pharmaceutical industry for a variety of processes, departments and products. It is also used in various associated processes, such as cleaning and as a solvent.

• 
  Alzheimer’s Disease: Charting the Course from Plaques to Promise Muhammad Farhan Khalid
  May 28, 2025
• 
  Henlius Licenses Phase 3 Innovative HER2 ADC from GeneQuantum Henlius
  August 20, 2025
• 
  Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies ACN Newswire
  August 02, 2025
  Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash.

• 
  Popular Products and Companies at PharmaSources.com (July 2025) PSI
  July 24, 2025
  Popular Products and Companies at PharmaSources.com
• 
  The Bitter Medicine is Good for Health: Research Progress on the Components and Pharmacological Activities of Coptis Chinensis Xiaomichong
  July 02, 2025
• 
  Popular Products and Companies at PharmaSources.com (January 2025) PSI
  January 15, 2025

• 
  Apeloa Pharmaceutical releases first ESG PharmaSources
  May 12, 2025
  Apeloa Pharmaceutical has released its first sustainability report. Apeloa’s 2024 Environmental, Social and Governance (ESG) report marks the start of continuous and responsible disclosure into the future.